Diagnosis and management of invasive candidiasis in the ICU: an updated approach to an old enemy

Crit Care. 2016 May 27;20(1):125. doi: 10.1186/s13054-016-1313-6.

Abstract

Invasive fungal infections, particularly those caused by Candida species, are not uncommon in critically ill patients and are associated with considerable morbidity and mortality. Diagnosis and management of these infections can be challenging. In this review, we will briefly discuss recent epidemiological data on invasive candidiasis and current diagnostic approaches before concentrating on antifungal treatments.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Antifungal Agents / pharmacology
  • Antifungal Agents / therapeutic use*
  • Candida albicans / pathogenicity
  • Candidiasis / diagnosis
  • Candidiasis / drug therapy*
  • Disease Management*
  • Fluconazole / pharmacology
  • Fluconazole / therapeutic use
  • Humans
  • Intensive Care Units*
  • Triazoles / pharmacology
  • Triazoles / therapeutic use

Substances

  • Antifungal Agents
  • Triazoles
  • Fluconazole